Foster City-Based Gilead’s Breakthrough Hepatitis Drug Costs $1,000 Per Pill

Doctors are calling a newly-approved drug a “revolution” in treating the most common blood-borne infection in the United States. But patient advocates warn how those who need it may not be able to afford it. Elizabeth Cook reports.